<

 
Data updated 2025-04-28 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date16756274.3 (espacenet)  (Federated)  (European Patent Register), 20160224
Patent/reg. no. and dateDK/EP 3261721, 20220914
Publication date20180103
Priority no. and dateUS 201562120771 P, 20150225, US 201562186221 P, 20150629
EP pub. no. and date EP 3261721 20180103
Effective date
Applicant/ownerThe Board of Regents of The University of Texas System, 201 West 7th Street
Austin, TX 78701, US,
Prilenia Neurotherapeutics Ltd., 10 HaMenofim Street
Herzliya 4672561, IL
Applicant ref. no.15919
InventorGEVA, Michal, Rozmarin 5
P.O.Box 7253
Even-Yehuda, IL,
BEZPROZVANNY, Ilya,
Dallas, TX 75205, US,
BASSAN, Merav,
Ramat Gan 5253179, IL,
HAYDEN, Michael,
Herzliya 4672561, IL
RepresentativeCOSMOVICI INTELLECTUAL PROPERTY, Rue de la Corraterie 5 1204 Geneva, CH
Opponent
IPC ClassA61K 31/451 (2006.01) , A61P 25/28 (2006.01) , C07D 211/24 (2006.01) 
TitleANVENDELSE AF PRIDOPIDIN TIL FORBEDRING AF HUKOMMELSE
Int. application no.US2016019357
Int. publication no.WO2016138130
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact